Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue suppl 6, Pages vi7-vi23
Publisher
Oxford University Press (OUP)
Online
2013-08-23
DOI
10.1093/annonc/mdt284
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
- (2013) Ellen Warner et al. ANNALS OF INTERNAL MEDICINE
- Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement†
- (2013) H. A. Azim et al. ANNALS OF ONCOLOGY
- Cancer prevalence estimates in Europe at the beginning of 2000
- (2013) G. Gatta et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial
- (2013) Diana Crivellari et al. BREAST
- Survival after lumpectomy and mastectomy for early stage invasive breast cancer
- (2013) E. Shelley Hwang et al. CANCER
- Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
- (2013) Viviana Galimberti et al. LANCET ONCOLOGY
- 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
- (2013) Xavier Pivot et al. LANCET ONCOLOGY
- Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
- (2012) S. Guiu et al. ANNALS OF ONCOLOGY
- Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: A meta-analysis of phase III randomized control trials
- (2012) Nan Shao et al. BREAST
- Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis
- (2012) Xiaosong Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002
- (2012) Claudia Allemani et al. INTERNATIONAL JOURNAL OF CANCER
- Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
- (2012) Valentina Guarneri et al. JOURNAL OF CLINICAL ONCOLOGY
- Mammographic Screening Programmes in Europe: Organization, Coverage and Participation
- (2012) Livia Giordano et al. JOURNAL OF MEDICAL SCREENING
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Assessing Radiologist Performance Using Combined Digital Mammography and Breast Tomosynthesis Compared with Digital Mammography Alone: Results of a Multicenter, Multireader Trial
- (2012) Elizabeth A. Rafferty et al. RADIOLOGY
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2011) S. Aebi et al. ANNALS OF ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- FDG-PET/CT in the staging of local/regional metastases in breast cancer
- (2011) Ian J. Robertson et al. BREAST
- Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry
- (2011) Seho Park et al. BREAST
- A population-based validation of the prognostic model PREDICT for early breast cancer
- (2011) G.C. Wishart et al. EJSO
- Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer
- (2011) Armando E. Giuliano et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
- (2011) Armando E. Giuliano JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study
- (2011) Judith M. Bliss et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data
- (2011) Angelo Di Leo et al. LANCET ONCOLOGY
- Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
- (2011) Meredith M Regan et al. LANCET ONCOLOGY
- Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Breast-Cancer Adjuvant Therapy with Zoledronic Acid
- (2011) Robert E. Coleman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial
- (2011) Erik van Werkhoven et al. RADIOTHERAPY AND ONCOLOGY
- ASCO-CAP Guidelines for Breast Predictive Factor Testing
- (2011) M. Elizabeth Hale Hammond APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
- (2010) H. Eidtmann et al. ANNALS OF ONCOLOGY
- Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
- (2010) Gunter von Minckwitz et al. BREAST CANCER RESEARCH AND TREATMENT
- Locoregional treatment of primary breast cancer
- (2010) Manfred Kaufmann et al. CANCER
- Quality indicators in breast cancer care
- (2010) M. Rosselli Del Turco et al. EUROPEAN JOURNAL OF CANCER
- Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group
- (2010) Francesco Sardanelli et al. EUROPEAN JOURNAL OF CANCER
- American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
- (2010) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Coprescription of Tamoxifen and Medications That Inhibit CYP2D6
- (2010) Kostandinos Sideras et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial
- (2010) Jayant S Vaidya et al. LANCET
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
- (2010) David N Krag et al. LANCET ONCOLOGY
- Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer
- (2010) Sandhya Pruthi et al. MAYO CLINIC PROCEEDINGS
- Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
- (2010) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
- (2010) Timothy J. Whelan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009)
- (2010) Csaba Polgár et al. RADIOTHERAPY AND ONCOLOGY
- Breast conservation and negative margins: how much is enough?
- (2009) M. Morrow BREAST
- Post-operative radiotherapy for ductal carcinoma in situ of the breast – A systematic review of the randomised trials
- (2009) Annabel Goodwin et al. BREAST
- Effect of postoperative radiotherapy on autologous deep inferior epigastric perforator flap volume after immediate breast reconstruction
- (2009) J. S. Chatterjee et al. BRITISH JOURNAL OF SURGERY
- Male breast cancer
- (2009) Laura Ottini et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller
- (2009) Ana M. Gonzalez-Angulo et al. JOURNAL OF CLINICAL ONCOLOGY
- Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
- (2009) Stephen Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer
- (2009) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
- (2009) Kathy S Albain et al. LANCET
- Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
- (2009) Kathy S Albain et al. LANCET ONCOLOGY
- Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
- (2009) Hyman B. Muss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- The challenges of success
- (2008) David Rew EJSO
- Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen
- (2008) Paul E. Goss et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27
- (2008) Priya Rastogi et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
- (2008) LANCET
- The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial
- (2008) LANCET ONCOLOGY
- High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b&c
- (2008) Marianne Kyndi et al. RADIOTHERAPY AND ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search